Literature DB >> 12408721

Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine.

Jean-Guy Delcros1, Sophie Tomasi, Simon Carrington, Bénédicte Martin, Jacques Renault, Ian S Blagbrough, Philippe Uriac.   

Abstract

Polyamines are believed to be potent vectors for the selective delivery of chemotherapeutic agents into cancer cells. In this paper, we report the effect of spermine conjugation on the cytotoxic and transport properties of acridine. Six derivatives, composed of a spermine chain attached at its N(1) position to an acridine via an aliphatic chain, were synthesized. The aliphatic linker, comprised of 3-5 methylene units, was connected to the position-9 of the heterocycle through either an amide (amidoacridines 8-10) or an amine (aminoacridines 11-13) linkage. Independently of their architecture, all ligands showed a high affinity for DNA binding but a limited DNA sequence selectivity. In a whole cell assay with L1210 and Chinese hamster ovary (CHO) cells, the aminoacridines (IC(50) values around 2 microM) were more potent than the amidoacridines (IC(50) values between 20 and 40 microM). This was related to a less efficient transport for the latter. As determined from competitive uptake studies with [(14)C]spermidine, all conjugates had a high affinity for the polyamine transport system (PTS). However, on the basis of competitive studies with an excess of spermidine and on the differential effect on cell growth and accumulation in CHO and in the mutant PTS deficient CHO-MG cells, the accumulation of the conjugates through the PTS was found to be poor but still more efficient for the aminoacridines. alpha-Difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, which induces an up-regulation of the activity of the PTS, enhanced accumulation of all acridine conjugates through the PTS and had a synergistic effect on the potency of the acridine conjugates to inhibit cell growth. Despite their high affinity for the PTS, the low amount of derivatives transiting through the PTS is likely to be related to their ability to repress rapidly and efficiently the activity of the PTS and, consequently, to inhibit their own uptake via this system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408721     DOI: 10.1021/jm020843w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors.

Authors:  Maris A Cinelli; Andrew Morrell; Thomas S Dexheimer; Evan S Scher; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2008-07-17       Impact factor: 7.446

2.  Design, Synthesis, and Testing of Polyamine Vectored Iron Chelators.

Authors:  Raymond J Bergeron; Shailendra Singh; Neelam Bharti; Yi Jiang
Journal:  Synthesis (Stuttg)       Date:  2010       Impact factor: 3.157

3.  Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.

Authors:  Katherine E Peterson; Maris A Cinelli; Andrew E Morrell; Akhil Mehta; Thomas S Dexheimer; Keli Agama; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2011-06-28       Impact factor: 7.446

4.  99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.

Authors:  Sabrina Pesnel; Yves Guminski; Arnaud Pillon; Stéphanie Lerondel; Thierry Imbert; Nicolas Guilbaud; Anna Kruczynski; Christian Bailly; Alain Le Pape
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-10       Impact factor: 9.236

5.  Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction.

Authors:  Avinash Muppidi; Xiaolong Li; Jiandong Chen; Qing Lin
Journal:  Bioorg Med Chem Lett       Date:  2011-10-12       Impact factor: 2.823

6.  Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: investigating the hypothesis of shared structure-activity relationships.

Authors:  Maris A Cinelli; Brenda Cordero; Thomas S Dexheimer; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2009-09-06       Impact factor: 3.641

7.  A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.

Authors:  Amin Haghighat Jahromi; Lien Nguyen; Yuan Fu; Kali A Miller; Anne M Baranger; Steven C Zimmerman
Journal:  ACS Chem Biol       Date:  2013-03-20       Impact factor: 5.100

8.  Design and synthesis of N4,N9-disubstituted spermines for non-viral siRNA delivery--structure-activity relationship studies of siFection efficiency versus toxicity.

Authors:  Moustafa K Soltan; Hassan M Ghonaim; Mohamed El Sadek; M Abou Kull; Lubna Abd El-aziz; Ian S Blagbrough
Journal:  Pharm Res       Date:  2008-10-09       Impact factor: 4.200

Review 9.  A journey in bioinspired supramolecular chemistry: from molecular tweezers to small molecules that target myotonic dystrophy.

Authors:  Steven C Zimmerman
Journal:  Beilstein J Org Chem       Date:  2016-01-25       Impact factor: 2.883

10.  Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.

Authors:  Yuan Fu; Kali A Miller; Lien Nguyen; Amin Haghighat Jahromi; Long M Luu; Anne M Baranger; Steven C Zimmerman
Journal:  J Med Chem       Date:  2013-11-21       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.